title: Real-life global survey evaluating patients with atrial fibrillation (REALISE-AF): results of an international observational registry.
abstract: Despite being one of the most studied arrhythmias, there is paucity of information regarding atrial fibrillation (AF) control in the general population and the treatment strategies utilized by healthcare providers. REALISE-AF is an ongoing international registry investigating the management of AF and its control in nonhospitalized subjects. The registry has enrolled patients in 26 countries worldwide with the primary aim to determine the control of AF. This article presents a review of the initial results from the REALISE-AF registry and compares it to major practice-changing clinical trials conducted in the past. It also gives an overview of the current management strategies, recent updates in treatment and what further developments portend in the future.
authors.affiliation: Memphis Veterans Affairs Medical Center, Memphis, TN, USA. mahboob02@gmail.com
authors.forename: Mahboob
authors.initials: M
authors.lastname: Alam
authors.forename: Salman Jamaluddin
authors.initials: SJ
authors.lastname: Bandeali
authors.forename: Saima A
authors.initials: SA
authors.lastname: Shahzad
authors.forename: Nasser
authors.initials: N
authors.lastname: Lakkis
mesh_terms: D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications / Q000503:physiopathology / Q000517:prevention & control*; D002318:Cardiovascular Diseases / Q000150:complications / Q000453:epidemiology; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D012042:Registries; D012307:Risk Factors
chemical_list: D000889:Anti-Arrhythmia Agents